Lapis Esg Analytics
ESG Global Medical Devices 25 Dividend Yield
The LAPIS ESG Global Medical Device 25 Dividend Yield Analysis is composed of 25 worldwide best-known and leading companies, with leading ESG qualities. All companies in our equally weighted equity index have a market capitalization greater than USD 5 billion and 80% of them have paid uninterrupted and continuously increasing dividends over the last 5 years. Hence, a maximum of 20% of the companies included in our unique equity analysis do not apply a strict dividend payment policy and have paid their regular dividends for less than 5 years.
Analysis facts
Transparent rules and disciplined signals that guide allocation through changing markets.
Asset class
EquityRegion
Lapis Esg AnalyticsCurrency
USDLaunch Date
01/01/2012Rebalancing
Semi-annually: end of April and OctoberCalculation
DailyNAV
537.63Chart performance
Jan 1, 2025
Jan 1, 2026
Performance
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | YTD | 1 Yr | 3 Yr avg | since inception avg | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LAPIS | 12.37% | 37.28% | 9.75% | 33.26% | 17.79% | 23.22% | -22.84% | 6.34% | 1.57% | 3.94% | -12.59% | -10.34% | -2.62% | 12.53% |
| Benchmark | 4.03% | 30.24% | 9.78% | 32.56% | 23.16% | 16.43% | -24.29% | 10.78% | 8.86% | 7.02% | -14.46% | -12.26% | 1.59% | 11.28% |
Constituents
Country breakdown
- Country
- USA56.00%
- Japan16.00%
- Others28.00%
Sector breakdown
- Sector
- Health Care100.00%

